Last updated on April 19, 2014 at 6:57 EDT

VIP Cocktail Reception With the Pharmaceutical Society of Sri Lanka and CPhI 17 October 2012, Colombo

October 17, 2012

MUMBAI, India, October 17, 2012 /PRNewswire/ –

The world’s largest pharmaceutical organiser CPhI, in collaboration with the
Pharmaceutical Society of Sri Lanka, is pleased to cordially invite you to an exclusive
VIP cocktail reception.

Date: Wednesday, 17 October 2012

Time: 5:00 pm

Venue: Hotel Galadari

Key industry representatives will discuss the future of this sector in Sri Lanka and
mark the official launch of ‘Sri Lanka Pharma Week’.

Sri Lanka Pharma Week will address the industry’s burning issues: Bioavailability and
Bioequivalence requirements, Pharma Sales Force Effectiveness and Automation, and Supply
Chain and Distribution. Industry experts will provide their expert insights through their
own experiences.

Sri Lanka Pharma Week will address the industry’s burning issues: Bioavailability and
Bioequivalence requirements, Pharma Sales Force Effectiveness and Automation, and
finishing on the topic of Pharma Supply Chain and Distribution. Industry experts will
provide their understanding of the given topics on display, while demonstrating relevant
procedures through case studies and speeches to delegates. Here’s a quick insight on what
the speakers at this event have to say about these issues in Sri Lanka

Mr K ShivKumar, Managing Director, Eisai Pharmaceuticals India, talks about the SFE
and SFA in pharmaceutical business, “SFE will be the key in exploiting the expanding SL
market. SFE will help in targeting the right customers by the sales force by answering the
key questions like – which markets, which target audience, why and how, how often and with
the right message. SFE will decide who will be the winners and losers”

Mr Himanshu Saxena, Vice President Supply Chain International Business, Alembic
Pharmaceuticals says “Supply chain and distribution is the most critical aspect of the
pharmaceutical business to ensure that drugs are delivered to the end patient quickly and
in safe conditions”. He adds that “Even if the manufacturing and production of drugs is
done using GMP norms, the products remain unfit for consumption if the safety of the drugs
is compromised en route to the end patient and since the pharmaceutical organisations in
Sri Lanka are custodians of the products, it is imperative that they ensure efficient
distribution network so that the patients can consume quality drugs and in time.” When
asked about his views on the Sri Lanka pharma week, here’s what he had to say “Emerging
countries like Sri Lanka can draw learnings on novel strategies adopted by countries like
India who have passed this stage and are still successfully dealing with similar
infrastructure issues in some of the states. At this forum, the Indian pharma supply chain
experts would be discussing practical implementable technologies to manage the supply
chain to maintain adequate stocks and manage demand cycles. This would eventually reduce
the pressure on the business and ensure that the sales are not affected.”

Bansri Shah, Managing Director, UBM (CPhI) says “We are grateful to Mr. Shalutha and
the Pharmaceutical Society of Sri Lanka for their help and support towards the development
of ‘Sri Lanka Pharma Week’.

“It also gives me immense pleasure to bring our largest brand CPhI to the rapidly
growing industry in Sri Lanka and we would like to extend a warm invitation to the
pharmaceutical fraternity to participate in this knowledge sharing.”

About PSSL

The Pharmaceutical Society of Sri Lanka is one of the country’s leading industry
associations with over 1,000 members. The association aims to uplift the industry and
create further opportunities for this growing sector.

About CPhI

CPhI is the world’s largest event organiser for the pharmaceutical industry bringing
together since 1990 over 250,000 attendees, 4000 exhibitors from over 133 countries. The
flagship event in Amsterdam hosts 2,200 exhibitors and is the market leader for the global
pharmaceutical ingredients industry. Large scale exhibitions and content-led conferences
also take place in India, South East Asia, China, Latin America and Turkey.


About UBM

UBM is a global live media and B2B communications, marketing service and data

We help organisations make connections, communicate their proposition and do business
effectively. We enable professional people in more than 40 countries around the world to
connect and engage with each other, with the markets they serve and with the information
they need to succeed. And we do this by whatever means works best – at live events,
through digital media or in publications.

Our 6,500 expert staff are deeply embedded in the many specialist communities we
serve, bringing both an unusual depth of understanding and real know-how. We organise
hundreds of live events each year; we provide data, marketing and information products; we
offer a portfolio of market-leading online and print titles; and we support professional
communicators through our targeting, distribution and monitoring services.

Our culture of innovation and collaboration brings our people together around common
interests to create value, enhancing our ability to do exactly the same for UBM customers.
So, whatever their business and wherever they operate, our customers do better business
through us. http://www.ubm.com

For further details, about participating at ‘Sri Lanka Pharma Week’, contact Mr
Jayadev Nair on Jayadev.nair@ubm.com [
Jayadev.nair@ubm.com&cc=conferences-india@ubm.com?subject=Sri%20Lanka%20Pharma%20Week ] or


Source: PR Newswire